PBE (PBE) Stock Price & Analysis
PBE (PBE) rose 2.12% to USD 84.25 as of June 10, 2026 at 11:56 UTC, according to Nexqual real-time market data.
PBE last closed at USD 82.5; the session ranged USD 82.92–84.25 on volume of 1,623 shares. Market capitalization is —, with a 52-week range of USD 62.63–85.73 (PCX). Source: Nexqual, June 10, 2026 at 11:56 UTC.
Key Statistics (as of June 10, 2026 at 11:56 UTC)
| Price | USD 84.25 |
|---|---|
| Change | ▲ 2.12% (up) |
| Previous Close | USD 82.5 |
| Open | USD 83.46 |
| Day Range | USD 82.92 – 84.25 |
| 52-Week Range | USD 62.63 – 85.73 |
| Volume | 1,623 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PBE)
Nexqual's technical model rates PBE "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 11:56 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.68 (neutral) |
| vs SMA50 | Above (USD 80.98) |
| MACD | 0.58 (positive) |
Financial Health Score (PBE)
Nexqual rates PBE's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 11:56 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PJP | Invesco Pharmaceuticals ETF | USD 112 | ▲ 1.09% |
| FBT | First Trust Amex Biotech Index | USD 226.09 | ▲ 1.5% |
| PBJ | Invesco Food & Beverage ETF | USD 47.53 | ▼ 0.69% |
| PKB | Invesco Building & Construction | USD 104.42 | ▲ 0.76% |
| BBH | VanEck Biotech ETF | USD 187.49 | ▼ 0.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 11:56 UTC. This page is informational and not investment advice.